Vertex Pharmaceuticals | VRTX - EPS Earnings Per Share

Stock Price
476.90
Daily Change
7.63 1.63%
Monthly
3.42%
Yearly
-1.52%
Q1 Forecast
462.12

Vertex Pharmaceuticals reported $5.03 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 5.03 5.12 3.98 Feb/12 2026
FY2025Q3 Sep/2025 4.80 4.62 4.38 Nov/03 2025
FY2025Q2 Jun/2025 4.52 4.32 -12.83 Aug/04 2025
FY2025Q1 Mar/2025 4.06 4.27 4.76 May/05 2025
FY2024Q4 Dec/2024 3.98 4.02 4.20 Feb/10 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
J&J USD 2.46 0.34 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.53 1.38 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
United Therapeutics USD 7.16 0.75 Sep/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025